EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax (NASDAQ:NVAX) Lowered to Hold Rating by Zacks Research
NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised
Novavax Boosts Revenue Outlook Amid Vaccine Demand Challenges, ETPharma
Novavax Q2 Earnings Call Highlights
Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Estimates By $0.06 EPS
Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ...
Novavax Slips To Loss In Q2 On Reduced Revenue, Cuts FY26 Guidance
Novavax (NASDAQ:NVAX) Exceeds Q2 CY2026 Expectations
Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights | Morningstar
Novavax lifts annual revenue forecast as licensing bets offset weak vaccine demand
NVAX Stock Rises Ahead Of Q2 Earnings As Focus Shifts To Licensing Deals
Edgestream Partners L.P. Makes New $4.23 Million Investment in Novavax, Inc. $NVAX - Daily Political
Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026
Novavax (NVAX) Expected to Post Earnings on Wednesday
Novavax (NVAX) Stock May Be Fully Priced Given Its Sales Outlook
Novavax, Inc. (NASDAQ:NVAX) Receives Average Rating of "Hold" from Brokerages
Novavax (NVAX) Could Be 32% Undervalued As Russell Index Exit Reshapes The View
Head to Head Contrast: Basilea Pharmaceutica (OTCMKTS:BPMUF) and Novavax (NASDAQ:NVAX) - Stock Observer
Latest news
Show moreRussia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict
Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions
Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis
